Ajax Health/Zeus Health is a company that deploys capital and provides operational expertise to accelerate healthcare innovation.
Location: South Korea, Chungcheongbuk-Do
Total raised: $305M
Investors 4
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Aisling Ca... | aislingcap... |
| - | HealthQues... | healthques... |
| 26.08.2021 | Kohlberg K... | kkr.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.09.2019 | - | $100M | - |
| 16.04.2019 | - | $85M | - |
| 13.07.2018 | Series B | $120M | - |
Mentions in press and media 19
| Date | Title | Description |
| 04.11.2024 | Boston Scientific to acquire Cortex and its cardiac mapping tech | Boston Scientific (NYSE: BSX) announced today that it will purchase Ajax Health’s Cortex and its FDA-cleared OptiMap system to guide physicians performing ablation procedures to treat AFib Financial terms of the deal were not disclosed. Bos... |
| 15.05.2024 | Cortex Announces Appointment of Dr. Matthew Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences, to its Board of Directors | Dr. Lungren brings expertise translating cutting-edge AI technology into valuable healthcare applications MENLO PARK, Calif., May 15, 2024 /PRNewswire/ -- Cortex, a medical technology company aiming to transform the diagnosis and treatment ... |
| 24.05.2021 | AcuityMD Nabs $7M for Targeting Platform for Medical Device Companies | What You Should Know: – AcuityMD, a platform for commercializing and improving medical devices with data announced it has raised $7M in funding led by Benchmark with participation from Ajax Health. Eric Vishria, General Partner at Benchmark... |
| 12.03.2021 | Cardinal Health : signs definitive agreement to sell its Cordis business to Hellman & Friedman | DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes ... |
| 12.03.2021 | CARDINAL HEALTH, INC. Cardinal Health : signs definitive agreement to sell its Cordis business to Hellman & Friedman | DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes ... |
| 12.03.2021 | Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman | March 12th, 2021 DUBLIN, Ohio Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer’s assum... |
| 12.03.2021 | Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman USA - English USA - English | |
| 30.09.2019 | Ajax Health raises $100 million to invest in MedTech startups developing disruptive technologies in the healthcare space | Ajax Health announced today that it has raised $100 million to form Ajax 3. The new capital will target investing in companies in the areas of medtech, healthcare services, and healthcare IT that focus on truly innovative approaches to addr... |
| 30.09.2019 | Ajax Health Closes Third $100M MedTech Innovation Fund | Duke Rohlen, Chairman and CEO, Ajax Health – Ajax Health raises $100M to close third medtech innovation, Ajax3 led by HealthQuest Capital with participation from Polaris Partners. – Led by Duke Rohlen, Chairman and CEO, Ajax3 quickly follow... |
| 30.09.2019 | Ajax Health Raises $100M to Form Ajax 3 | Ajax Health, a Menlo Park, Calif.-based investor in the healthcare space, raised $100m to form Ajax 3. The capital will target investing in companies in the areas of medtech, healthcare services, and healthcare IT that focus on innovative a... |
Show more